Is HCAT overvalued or undervalued? | Glauxie AI

The consensus price target for HCAT is $1.75, implying +35.7% from the current price of $1.29 (1 analysts). Valuation: trailing P/E -0.35.

Calculate HCAT fair value using DCF, earnings power, and peer comparison models.

Get HCAT trailing and forward PE ratios compared to sector peers and historical averages.

View the latest analyst price targets for HCAT, including consensus, high, low, and implied upside.

Is HCAT overvalued or undervalued?

🦉

HCAT Price Target & Valuation

Current price: $1.29

EV/EBITDA-1.80x

HCAT Overview Analyst Ratings Financials

What is HCAT fair value? What is HCAT PE ratio? What is HCAT price target? Is HCAT a buy?

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms